Long-term Safety of Human Retinal Progenitor Cell Transplantation in Retinitis Pigmentosa Patients

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2017 Oct 1

PMID 28962643

Citations 57

Authors

Yong Liu

Shao Jun Chen

Shi Ying Li

Ling Hui Qu

Xiao Hong Meng

Yi Wang

Hai Wei Xu

Zhi Qing Liang

Zheng Qin Yin

Affiliations

Soon will be listed here.

Abstract

Background: Retinitis pigmentosa is a common genetic disease that causes retinal degeneration and blindness for which there is currently no curable treatment available. Vision preservation was observed in retinitis pigmentosa animal models after retinal stem cell transplantation. However, long-term safety studies and visual assessment have not been thoroughly tested in retinitis pigmentosa patients.

Methods: In our pre-clinical study, purified human fetal-derived retinal progenitor cells (RPCs) were transplanted into the diseased retina of Royal College of Surgeons (RCS) rats, a model of retinal degeneration. Based on these results, we conducted a phase I clinical trial to establish the safety and tolerability of transplantation of RPCs in eight patients with advanced retinitis pigmentosa. Patients were studied for 24 months.

Results: After RPC transplantation in RCS rats, we observed moderate recovery of vision and maintenance of the outer nuclear layer thickness. Most importantly, we did not find tumor formation or immune rejection. In the retinis pigmentosa patients given RPC injections, we also did not observe immunological rejection or tumorigenesis when immunosuppressive agents were not administered. We observed a significant improvement in visual acuity (P < 0.05) in five patients and an increase in retinal sensitivity of pupillary responses in three of the eight patients between 2 and 6 months after the transplant, but this improvement did not appear by 12 months.

Conclusion: Our study for the first time confirmed the long-term safety and feasibility of vision repair by stem cell therapy in patients blinded by retinitis pigmentosa.

Trial Registration: WHO Trial Registration, ChiCTR-TNRC-08000193 . Retrospectively registered on 5 December 2008.

Citing Articles

Study protocol for a prospective natural history registry investigating the relationships between inflammatory markers and disease progression in retinitis pigmentosa: the RP-PRIMARY study.

Murakami Y, Hisai T, Shimokawa S, Fukushima M, Fujiwara K, Hirata A Jpn J Ophthalmol. 2025; .

PMID: 40042698 DOI: 10.1007/s10384-025-01179-2.

Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.

Conditional Immortalization Using SV40 Large T Antigen and Its Effects on Induced Pluripotent Stem Cell Differentiation Toward Retinal Progenitor Cells.

Wang Q, Allen B, Bohrer L, Burnight E, Tucker B, Worthington K Stem Cells Dev. 2024; 34(1-2):26-34.

PMID: 39611948 PMC: 11839531. DOI: 10.1089/scd.2024.0124.

Subretinal microglia support donor photoreceptor survival in rd1 mice.

Ren Q, Lu F, Hao R, Chen Y, Liang C Stem Cell Res Ther. 2024; 15(1):436.

PMID: 39563450 PMC: 11575076. DOI: 10.1186/s13287-024-04052-0.

Unveiling Drivers of Retinal Degeneration in RCS Rats: Functional, Morphological, and Molecular Insights.

Ahluwalia K, Du Z, Martinez-Camarillo J, Naik A, Thomas B, Pollalis D Int J Mol Sci. 2024; 25(7).

PMID: 38612560 PMC: 11011632. DOI: 10.3390/ijms25073749.

References

FitzGibbon T . Retinal prosthesis that incorporates the organization of the nerve fibre layer. Clin Exp Ophthalmol. 2017; 45(4):401-408. DOI: 10.1111/ceo.12899. View

Cui L, Guan Y, Qu Z, Zhang J, Liao B, Ma B . WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors. J Clin Invest. 2013; 123(4):1647-61. PMC: 3613909. DOI: 10.1172/JCI65048. View

Luo J, Baranov P, Patel S, Ouyang H, Quach J, Wu F . Human retinal progenitor cell transplantation preserves vision. J Biol Chem. 2014; 289(10):6362-6371. PMC: 3945303. DOI: 10.1074/jbc.M113.513713. View

Odeberg J, Piao J, Samuelsson E, Falci S, Akesson E . Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J Neuroimmunol. 2005; 161(1-2):1-11. DOI: 10.1016/j.jneuroim.2004.11.016. View

Jiang L, Jorquera M, Streilein J . Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci. 1993; 34(12):3347-54. View

Pearson R, Barber A, Rizzi M, Hippert C, Xue T, West E . Restoration of vision after transplantation of photoreceptors. Nature. 2012; 485(7396):99-103. PMC: 3888831. DOI: 10.1038/nature10997. View

Schmitt S, Aftab U, Jiang C, Redenti S, Klassen H, Miljan E . Molecular characterization of human retinal progenitor cells. Invest Ophthalmol Vis Sci. 2009; 50(12):5901-8. DOI: 10.1167/iovs.08-3067. View

Humayun M, de Juan Jr E, Cerro M, Dagnelie G, Radner W, Sadda S . Human neural retinal transplantation. Invest Ophthalmol Vis Sci. 2000; 41(10):3100-6. View

Gonzalez-Cordero A, West E, Pearson R, Duran Y, Carvalho L, Chu C . Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat Biotechnol. 2013; 31(8):741-7. PMC: 3826328. DOI: 10.1038/nbt.2643. View

10.

MacLaren R, Pearson R, MacNeil A, Douglas R, Salt T, Akimoto M . Retinal repair by transplantation of photoreceptor precursors. Nature. 2006; 444(7116):203-7. DOI: 10.1038/nature05161. View

11.

Marmor M, Fulton A, Holder G, Miyake Y, Brigell M, Bach M . ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2008; 118(1):69-77. DOI: 10.1007/s10633-008-9155-4. View

12.

Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T . Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2012; 120(1):100-5. DOI: 10.1016/j.ophtha.2012.07.006. View

13.

Semo M, Haamedi N, Stevanato L, Carter D, Brooke G, Young M . Efficacy and Safety of Human Retinal Progenitor Cells. Transl Vis Sci Technol. 2016; 5(4):6. PMC: 4959814. DOI: 10.1167/tvst.5.4.6. View

14.

OBrien K, Schulte D, Hendrickson A . Expression of photoreceptor-associated molecules during human fetal eye development. Mol Vis. 2003; 9:401-9. View

15.

Liu Y, Yang X, Utheim T, Guo C, Xiao M, Liu Y . Correlation of cytokine levels and microglial cell infiltration during retinal degeneration in RCS rats. PLoS One. 2013; 8(12):e82061. PMC: 3862575. DOI: 10.1371/journal.pone.0082061. View

16.

Tucker B, Park I, Qi S, Klassen H, Jiang C, Yao J . Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One. 2011; 6(4):e18992. PMC: 3084746. DOI: 10.1371/journal.pone.0018992. View

17.

Khanna H, Akimoto M, Siffroi-Fernandez S, Friedman J, Hicks D, Swaroop A . Retinoic acid regulates the expression of photoreceptor transcription factor NRL. J Biol Chem. 2006; 281(37):27327-34. PMC: 1592579. DOI: 10.1074/jbc.M605500200. View

18.

Berger A, Tezel T, Del Priore L, Kaplan H . Photoreceptor transplantation in retinitis pigmentosa: short-term follow-up. Ophthalmology. 2003; 110(2):383-91. DOI: 10.1016/S0161-6420(02)01738-4. View

19.

Radtke N, Aramant R, Petry H, Green P, Pidwell D, Seiler M . Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol. 2008; 146(2):172-182. DOI: 10.1016/j.ajo.2008.04.009. View

20.

Das T, Cerro M, Jalali S, Rao V, Gullapalli V, Little C . The transplantation of human fetal neuroretinal cells in advanced retinitis pigmentosa patients: results of a long-term safety study. Exp Neurol. 1999; 157(1):58-68. DOI: 10.1006/exnr.1998.6992. View